Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0002-9378(53)90067-2 | DOI Listing |
Cureus
September 2024
Department of Pathology, Post Graduate Institute of Child Health, Noida, IND.
Acta Obstet Gynecol Scand
July 2024
National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
J Thromb Haemost
May 2024
Hemostasis and Thrombosis Center, Northwell Health, New Hyde Park, New York, USA.
Congenital fibrinogen disorders (CFDs) are a heterogeneous group of rare congenital quantitative and/or qualitative fibrinogen deficiencies. The spectrum of molecular anomalies is broad, leading to several subtypes of fibrinogen disorders (ie, afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia, and hypodysfibrinogenemia). Pregnancy in women with CFDs is a high-risk clinical situation, with an increased tendency for miscarriages, bleeding, and thrombosis.
View Article and Find Full Text PDFUltrasound Obstet Gynecol
June 2024
Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.
Objective: Management of placenta accreta spectrum (PAS) with the placenta kept in situ aims to preserve fertility and minimize blood loss. However, this method is associated with a risk of coagulopathy and subsequent bleeding. The aim of this study was to evaluate the occurrence and pathophysiology of coagulopathy in cases of PAS managed conservatively.
View Article and Find Full Text PDFZhonghua Yi Xue Yi Chuan Xue Za Zhi
November 2023
Harbin Institute of Hematological Oncology, Harbin First Hospital Affiliated to Harbin Institute of Technology, Harbin, Heilongjiang 150010, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!